Clarus Announces Extension of Its Tender Offer SALT LAKE

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
815
Clarus Announces Extension of Its Tender Offer

SALT LAKE CITY, June 05, 2018 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR ) (“Clarus,” “Company,” “we,” “us” or “our”) announced today that it is extending the expiration time of its previously announced tender offer (the “Tender Offer”) from 11:59 P.M., New York City time, Tuesday, June 5, 2018, to 11:59 P.M., New York City time, Friday, June 22, 2018, unless the Tender Offer is further extended.

The Tender Offer is for Clarus’ common stock, par value $0.0001 per share, as well as the preferred share purchase rights associated with such shares (collectively, the “Shares”), for an aggregate cash purchase price of up to $7,200,000 and at a per share price not greater than $7.20 nor less than $6.60, with the exact price to be determined through a “modified Dutch auction.” The Tender Offer consideration has not been modified. As of market close on June 5, 2018, American Stock Transfer & Trust Company, LLC, the depositary for the offer, has advised that approximately 16,578 Shares have been tendered and not withdrawn.  Stockholders who have already tendered their shares do not have to re-tender their Shares or take any other action as a result of the extension of the expiration date of the Tender Offer. 

The full terms and conditions of the Tender Offer are described in the Offer to Purchase, dated May 8, 2018 (as amended, the “Offer to Purchase”), the associated Letter of Transmittal and other materials relating to the Tender Offer that Clarus filed on May 8, 2018 with the Securities and Exchange Commission (“SEC”) and the amendment to Schedule TO filed with the SEC on June 5, 2018 (the “Amendment”).  The Tender Offer is not contingent upon obtaining any financing. However, the Tender Offer is subject to a number of other terms and conditions, which are described in the Offer to Purchase.

None of Clarus, the members of its board of directors, its executive officers, the information agent or the depositary for the Tender Offer are making any recommendation to stockholders as to whether to tender or refrain from tendering their Shares or as to any price at which they might tender their Shares. Stockholders must make their own decisions as to whether to tender their Shares and, if so, how many Shares to tender and at what price or prices to tender. Prior to making any decision with respect to the Tender Offer, stockholders should read carefully the information in the Offer to Purchase, the related Letter of Transmittal, and the Amendment, including the information regarding the purposes and effects of the Tender Offer, and should consult their own broker or other financial and tax advisors.

D.F. King & Co., Inc. is the information agent for the Tender Offer and stockholders seeking additional information about the Tender Offer and process should call or email them at (888) 414-5566 (toll free) or clarus@dfking.com .

About Clarus Corporation

Clarus Corporation is focused on the outdoor and consumer industries, seeking opportunities to acquire and grow businesses that can generate attractive stockholder returns. The Company has substantial net operating tax loss carryforwards which it is seeking to redeploy to maximize stockholder value. Clarus’ primary business is as a leading developer, manufacturer and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, and sport categories. The Company’s products are principally sold under the Black Diamond®, Sierra® and PIEPS® brand names through specialty and online retailers, distributors and original equipment manufacturers throughout the U.S. and internationally. For additional information, please visit www.claruscorp.com  or the brand websites at www.blackdiamondequipment.com , www.sierrabullets.com  or www.pieps.com .

Additional Information Regarding the Tender Offer

This press release is for informational purposes only. This press release is not a recommendation to buy or sell Shares or any other securities, and it is neither an offer to purchase nor a solicitation of an offer to sell Shares or any other securities. On May 8, 2018, a tender offer statement on Schedule TO, including the Offer to Purchase, the Letter of Transmittal and related materials, was filed with the SEC by Clarus. On June 5, 2018, Clarus filed the Amendment. The Tender Offer is only being made pursuant to the Offer to Purchase, the Letter of Transmittal, the Amendment and related materials filed as a part of the Schedule TO. Stockholders should read carefully the Offer to Purchase, Letter of Transmittal, the Amendment and related materials because they contain important information, including the various terms of, and conditions to, the Tender Offer. Stockholders may obtain a free copy of the tender offer statement on Schedule TO, the Offer to Purchase, Letter of Transmittal, the Amendment and other documents that Clarus has filed with the SEC at the SEC’s website at  www.sec.gov , from Clarus’ website at www.claruscorp.com  or by calling or emailing D.F. King & Co., Inc., the information agent for the Tender Offer, at (888) 414-5566 (toll free) or clarus@dfking.com . Stockholders are urged to read these materials carefully prior to making any decision with respect to the offer.

Forward-Looking Statements

Please note that in this press release we may use words such as “appears,” “anticipates,” “believes,” “plans,” “expects,” “intends,” “future,” and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements. Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this release include, but are not limited to, the overall level of consumer spending on our products; general economic conditions and other factors affecting consumer confidence; disruption and volatility in the global capital and credit markets, including the ability to obtain sufficient financing; the financial strength of the Company’s customers; the Company’s ability to implement its growth strategy, including its ability to organically grow each of its historical product lines, the ability of the Company to identify potential acquisition or investment opportunities as part of its acquisition strategy; the Company’s ability to successfully execute its acquisition strategy or that any such strategy will result in the Company’s future profitability; the Company’s ability to successfully integrate Sierra Bullets, L.L.C.; changes in governmental regulation, legislation or public opinion relating to the manufacture and sale of bullets by our Sierra segment, and the possession and use of firearms and ammunition by our customers; the Company’s exposure to product liability or product warranty claims and other loss contingencies; stability of the Company’s manufacturing facilities and foreign suppliers; the Company’s ability to protect patents, trademarks and other intellectual property rights; any breaches of, or interruptions in, our information systems; fluctuations in the price, availability and quality of raw materials and contracted products as well as foreign currency fluctuations; our ability to utilize our net operating loss carryforwards; legal, regulatory, political and economic risks in international markets; the additional leverage that we may incur to finance the Tender Offer could adversely affect our capital resources, financial condition and liquidity; our decreased “public float” (the number of Shares owned by non-affiliate stockholders and available for trading in the securities markets) as a result of the Tender Offer and other share repurchases; and the commencement and completion of the Tender Offer. More information on potential factors that could affect the Company’s financial results is included from time to time in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release, and speak only as of the date hereof. We assume no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release.

Company Contact:

Warren B. Kanders Executive Chairman Tel 1-203-552-9600 warren.kanders@claruscorp.com or John C. Walbrecht President Tel 1-801-993-1344 john.walbrecht@claruscorp.com or Aaron J. Kuehne Chief Administrative Officer and Chief Financial Officer Tel 1-801-993-1364 aaron.kuehne@claruscorp.com

Investor Relations:

Liolios Cody Slach Tel 1-949-574-3860 CLAR@liolios.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nomada Fund Launches: A Game-Changer in New Media

Updated Category News Views 0

Changing the Investment Game In a world where tech isn't the only kingmaker, distribution is the new play. Welcome the Nomada Fund, a fresh face on the investment scene that's swapping cash for exposure. Forget the traditional media-for-equity model that only old-timers still drool over—these guys are taking it up a notch with their new Distribution for Equity approach,...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 56

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 0

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
AI-Designed Antivirals: A Brave New World

Updated Category News Views 1

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 0

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading
TomoIQ Unveils Money Finder at Money20/20 Event

Updated Category News Views 0

Breaking Down Financial Barriers with AI In the hustle of Money20/20 USA in Las Vegas, TomoIQ dropped a financial bombshell with their latest tool, Money Finder. This isn't just another app in the sea of fintech solutions. Nope, this one promises to cut through the complexities that most folks face when trying to get their financial house in order. An AI Buddy for...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 41

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Updated Category News Views 0

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 40

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Jovani's Innovative Approach to Affordable Sustainable Fashion

Updated Category News Views 253

Understanding Gen Z's Fashion Preferences Young consumers today are navigating a complex landscape of fashion choices, often caught between the desire for quality and the struggle with affordability. A recent trend highlights this dilemma within Generation Z, where the majority prioritize sustainability but consistently return to fast fashion options due to lower prices....

Continue Reading
Steve Cohen Shifts Focus to Growth at Point72 Asset Management

Updated Category News Views 217

Steve Cohen's New Direction at Point72 Asset Management In a major development reported by Bloomberg News, billionaire Steve Cohen, founder of Point72 Asset Management, has made the notable decision to step back from active trading. This strategic change aims to bolster the firm's growth trajectory and adapt to the shifting landscape of asset management. Mentoring Future...

Continue Reading
Opportunity for Methode Electronics, Inc. Investors to Join Class Action

Updated Category News Views 125

Class Action Lawsuit Filed for Methode Electronics, Inc. Investors Bronstein, Gewirtz & Grossman, LLC, a well-respected law firm specializing in investor rights, has announced that a class action lawsuit has been filed against Methode Electronics, Inc. (NYSE: MEI) and its management team. This lawsuit is particularly important for investors who may have experienced...

Continue Reading
NORBIT ASA Proposes NOK 3.00 Dividend for 2024 Fiscal Year

Updated Category News Views 268

NORBIT ASA Announces Proposed Cash Dividend NORBIT ASA has made an important announcement regarding the proposed cash dividend to be paid to its shareholders. As part of their ongoing commitment to return value to investors, the board of directors has put forth a resolution suggesting a dividend of NOK 3.00 per share for the fiscal year 2024. This proposal will be...

Continue Reading
Settlement Reached for Pilgrim's Pride Corporation Investors

Updated Category News Views 311

Understanding the Proposed Settlement for Pilgrim's Pride Corporation A notable development has emerged regarding the Pilgrim's Pride Corporation and its securities, which will impact everyone who has bought or otherwise acquired shares in the company. A proposed settlement has been announced, aiming to provide clarity and potential compensation for affected investors....

Continue Reading